Company rhetoric protected under Safe-Harbor laws or newspaper report from a reliable writer? Something else????
Such reports from a Phase 2 study neither guarantees a Phase 3 clinical trial or much of anything else without some bux be attracted to co-venture, partner, or just finance further studies.